Toracchio Sonia, Kozinetz Claudia A, Killen Deanna E, Sheehan Andrea M, Banez Eugenio I, Ittmann Michael M, Sroller Vojtech, Butel Janet S
Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030-3498, USA.
J Clin Virol. 2009 Oct;46(2):154-60. doi: 10.1016/j.jcv.2009.06.023. Epub 2009 Jul 23.
Studies have reported differing frequencies of detection of polyomavirus simian virus 40 (SV40) in association with human lymphomas.
We addressed the hypothesis that SV40 positivity in lymphomas can vary among sampled populations.
Archival paraffin-embedded lymphoma specimens (n=171) from patients at two urban hospitals in Houston, TX, USA, were analyzed following a cross-sectional study design. Extracted DNAs were characterized by quantitative polymerase chain reaction for the cellular RNase P gene and for SV40 and herpesvirus Epstein-Barr virus (EBV) sequences.
Patient characteristics of the two study populations differed significantly whereas the classification of tumor types studied did not. SV40 DNA was detected more frequently in lymphomas from the public hospital population (10/44, 23%) than in lymphomas from the veterans' hospital (VAMC) (4/127, 3%; P<0.0001). EBV detection in lymphomas also differed between the two groups (17/44, 39% vs. 23/127, 18%; P=0.01). SV40 positivity was associated with a younger age category of VAMC lymphoma patients (P=0.02). Expression of T-antigen was detected by immunohistochemistry in half of lymphomas that contained SV40 DNA. Variation was observed in the quality and quantity of DNA recovered from paraffin-embedded specimens, but there was no difference in recoveries of DNA from samples from the two hospitals.
This study demonstrated that, in a direct comparison, the prevalence of SV40 DNA in lymphomas can differ significantly between groups with different demographic distributions.
研究报告了与人类淋巴瘤相关的多瘤病毒猴病毒40(SV40)的不同检测频率。
我们探讨了淋巴瘤中SV40阳性在不同抽样人群中可能存在差异的假设。
采用横断面研究设计,分析了来自美国德克萨斯州休斯顿市两家城市医院患者的171份存档石蜡包埋淋巴瘤标本。提取的DNA通过定量聚合酶链反应对细胞核糖核酸酶P基因、SV40和疱疹病毒爱泼斯坦-巴尔病毒(EBV)序列进行鉴定。
两个研究人群的患者特征有显著差异,而所研究的肿瘤类型分类没有差异。公立医院人群的淋巴瘤中SV40 DNA的检测频率(10/44,23%)高于退伍军人医院(VAMC)的淋巴瘤(4/127,3%;P<0.0001)。两组淋巴瘤中EBV的检测也存在差异(17/44,39%对23/127,18%;P=0.01)。SV40阳性与VAMC淋巴瘤患者较年轻的年龄组相关(P=0.02)。通过免疫组织化学在含有SV40 DNA的一半淋巴瘤中检测到T抗原的表达。从石蜡包埋标本中回收的DNA在质量和数量上存在差异,但两家医院样本的DNA回收率没有差异。
本研究表明,在直接比较中,淋巴瘤中SV40 DNA的患病率在不同人口统计学分布的组之间可能存在显著差异。